全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
药学学报  2014 

低氧应激因子phd2与血管新生相关疾病

, PP. 151-157

Keywords: 低氧应激,phd2,血管新生治疗,肿瘤血管新生

Full-Text   Cite this paper   Add to My Lib

Abstract:

phds家族是低氧应激的重要调控因子,通过调控低氧诱导因子hifs的稳定性和活性,使细胞和组织适应低氧应激环境。其中,phd2作为phds家族中的重要一员,是低氧诱导因子hif-1的关键调控因子。近年研究表明,phd2不仅在缺血性疾病的血管新生中起重要作用,还能通过调控肿瘤生长、转移等相关基因的表达,影响肿瘤微环境下肿瘤的生长及转移。本文就phd2的分子调控机制及其在生理病理过程中的作用机制进行综述,重点介绍phd2在血管再生治疗和肿瘤血管新生中的作用,以及目前phd2作为治疗靶标的开发应用研究。

References

[1]  wanggl,jiangbh,rueea,etal.hypoxia-induciblefactor1isabasic-helix-loop-helix-pasheterodimerregulatedbycellularo2tension[j].procnatlacadsciusa,1995,92:5510-5514.
[2]  kaelinwg.prolinehydroxylationandgeneexpression[j].annurevbiochem,2005,74:115-128.
[3]  taylorms.characterizationandcomparativeanalysisoftheeglngenefamily[j].gene,2001,275:125-132.
[4]  appelhoffrj,tianym,ravalrr,etal.differentialfunctionoftheprolylhydroxylasesphd1,phd2,andphd3intheregulationofhypoxia-induciblefactor[j].jbiolchem,2004,279:38458-38465.
[5]  metzene,berchner-pfannschmidtu,stengelp,etal.intracellularlocalisationofhumanhif-1αhydroxylases:implicationsforoxygensensing[j].jcellsci,2003,116:1319-1326.
[6]  majmundaraj,wongwj,simonmc.hypoxia-induciblefactorsandtheresponsetohypoxicstress[j].molcell,2010,40:294-309.
[7]  minamishimaya,moslehij,bardeesyn,etal.somaticinactivationofthephd2prolylhydroxylasecausespolycythemiaandcongestiveheartfailure[j].blood,2008,111:3236-3244.
[8]  berrae,benizrie,ginouvesa,etal.hifprolyl-hydroxylase2isthekeyoxygensensorsettinglowsteady-statelevelsofhif-1αinnormoxia[j].emboj,2003,22:4082-4090.
[9]  nangakum,kojimai,tanakat,etal.noveldrugsandtheresponsetohypoxia:hifstabilizersandprolylhydroxylase[j].recentpatcardiovascdrugdiscov,2006,1:129-139.
[10]  kaelinwgjr.vonhippel-lindaudisease[j].annurevpathol,2007,2:145-173.
[11]  maxwellph,wiesenerms,changgw,etal.thetumoursuppressorproteinvhltargetshypoxia-induciblefactorsforoxygen-dependentproteolysis[j].nature,1999,399:271-275.
[12]  jaakkolap,moledr,tianym,etal.targetingofhif-αtothevonhippel-lindauubiquitylationcomplexbyo2-regulatedprolylhydroxylation[j].science,2001,292:468-472.
[13]  kalliopj,wilsonwj,o'briens,etal.regulationofthehypoxia-inducibletranscriptionfactor1alphabytheubiquitin-proteasomepathway[j].jbiolchem,1999,274:6519-6525.
[14]  fonggh,takedak.roleandregulationofprolylhydroxylasedomainproteins[j].celldeathdiffer,2008,15:635-641.
[15]  yuf,whitesb,zhaoq,etal.hif-1αbindingtovhlisregulatedbystimulus-sensitiveprolinehydroxylation[j].procnatlacadsciusa,2001,98:9630-9635.
[16]  marxsenjh,stengelp,doegek,etal.hypoxia-induciblefactor-1(hif-1)promotesitsdegradationbyinductionofhif-α-prolyl-4-hydroxylases[j].biochemj,2004,381:761-767.
[17]  leeka,lyndjd,o'reillys,etal.thebiphasicroleofthehypoxia-induciblefactorprolyl-4-hydroxylase,phd2,inmodulatingtumor-formingpotential[j].molcancerres,2008,6:829-842.
[18]  muchnike,kaplanj.hifprolylhydroxylaseinhibitorsforanemia[j].expertopininvestigdrugs,2011,20:645-656.
[19]  carmelietp,jainrk.molecularmechanismsandclinicalapplicationsofangiogenesis[j].nature,2011,473:298-307.
[20]  baowk,qinp,needles,etal.chronicinhibitionofhypoxia-induciblefactorprolyl4-hydroxylaseimprovesventricularperformance,remodeling,andvascularityaftermyocardialinfarctionintherat[j].jcardiovascpharmacol,2010,56:147-155.
[21]  huangm,chanda,jiafj,etal.shorthairpinrnainterferencetherapyforischemicheartdisease[j].circulation,2008,118:s226-s233.
[22]  ozera,wulc,bruickrk.thecandidatetumorsuppressoring4repressesactivationofthehypoxiainduciblefactor(hif)[j].procnatlacadsciusa,2005,102:7481-7486.
[23]  dangdt,chenf,gardnerlb,etal.hypoxia-induciblefactor-1αpromotesnonhypoxia-mediatedproliferationincoloncancercellsandxenografts[j].cancerres,2006,66:1684-1936.
[24]  jainrk.normalizationoftumorvasculature:anemergingconceptinantiangiogenictherapy[j].science,2005,307:58-62.
[25]  moslehij,minamishimaya,shijr,etal.lossofhypoxia-induciblefactorprolylhydroxylaseactivityincardiomyocytesphenocopiesischemiccardiomyopathy[j].circulation,2010,122:1004-1016.
[26]  sharmaak,khannad.diabetesmellitusassociatedcardio­vascularsignallingalteration:aneedfortherevisit[j].cellsignal,2013,25:1149-1155.
[27]  kaelinwgjr,ratcliffepj.oxygensensingbymetazoans:thecentralroleofthehifhydroxylasepathway[j].molcell,2008,30:393-402.
[28]  wangjj,lij,gengmy.recentprogressinthestudyonantitumordrugstargetinghypoxia-induciblefactor-1[j].actapharmsin(药学学报),2008,43:565-569.
[29]  gongcy,lub,yangl,etal.bibenzylfromdendrobiuminhibitsangiogenesisanditsunderlyingmechanism[j].actapharmsin(药学学报),2013,48:337-342.
[30]  bruickrk,mcknightsl.aconservedfamilyofprolyl-4-hydroxylasesthatmodifyhif[j].science,2001,294:1337-1340.
[31]  epsteinac,gleadlejm,mcneillla,etal.c.elegansegl-9andmammalianhomologsdefineafamilyofdioxygenasesthatregulatehifbyprolylhydroxylation[j].cell,2001,107:43-54.
[32]  hirsiläm,koivunenp,günzlerv,etal.characterizationofthehumanprolyl4-hydroxylasesthatmodifythehypoxia-induciblefactor[j].jbiolchem,2003,278:30772-30780.
[33]  pany,mansfieldkd,bertozzicc,etal.multiplefactorsaffectingcellularredoxstatusandenergymetabolismmodulatehypoxia-induciblefactorprolylhydroxylaseactivityinvivoandinvitro[j].molcellbiol,2007,27:912-925.
[34]  selakma,armoursm,mackenzieed,etal.succinatelinkstcacycledysfunctiontooncogenesisbyinhibitinghif-αprolylhydroxylase[j].cancercell,2005,7:77-85.
[35]  chenyr,daiag,hurc,etal.differentialandreciprocalregulationbetweenhypoxia-induciblefactor-alphasubunitsandtheirprolylhydroxylasesinpulmonaryarteriesofratwithhypoxia-inducedhypertension[j].actabiochimbiophyssin(生物化学与生物物理学报),2006,38:423-434.
[36]  suy,loosm,giesen,etal.prolylhydroxylase-2(phd2)exertstumor-suppressiveactivityinpancreaticcancer[j].cancer,2012,118:960-972.
[37]  wottawam,leiseringp,ahlenm,etal.knockdownofprolyl-4-hydroxylasedomain2inhibitstumorgrowthofhumanbreastcancermda-mb-231cellsbyaffectingtgf-β1processing[j].intjcancer,2013,132:2787-2798.
[38]  zagzagd,zhongh,scalzittijm,etal.expressionofhypoxia-induciblefactor1alphainbraintumors:associationwithangiogenesis,invasion,andprogression[j].cancer,2000,88:2606-2618.
[39]  jainrk.molecularregulationofvesselmaturation[j].natmed,2003,9:685-693.
[40]  hickeymm,simonmc.regulationofangiogenesisbyhypoxiaandhypoxia-induciblefactors[j].currtopdevbiol,2006,76:217-257.
[41]  dewhirstmw.relationshipsbetweencyclinghypoxia,hif-1,angiogenesisandoxidativestress[j].radiatres,2009,172:653-665.
[42]  chenjx,stinnetta.ang-1genetherapyinhibitshypoxia-induciblefactor-1α(hif-1α)-prolyl-4-hydroxylase-2,stabilizeshif-1αexpression,andnormalizesimmaturevasculatureindb/dbmice[j].diabetes,2008,57:3335-3343.
[43]  resniker,herronjm,lyusc,etal.developmentalregulationofhypoxia-induciblefactor1andprolyl-hydroxylasesinpulmonaryvascularsmoothmusclecells[j].procnatlacadsciusa,2007,104:18789-18794.
[44]  takedak,fonggh.prolylhydroxylasedomain2proteinsuppresseshypoxia-inducedendothelialcellproliferation[j].hypertension,2007,49:178-184.
[45]  tokkw,huangle.suppressionofhypoxia-induciblefactor1α(hif-1α)transcriptionalactivitybythehifprolylhydroxylaseegln1[j].jbiolchem,2005,280:38102-38107.
[46]  uhodar,heuschlinga,sattaria,etal.multifocaldiabeticmyonecrosis[j].revmedbrux,2012,33:545-548.
[47]  ratanrr,siddiqa,smirnovan,etal.harnessinghypoxicadaptationtoprevent,treat,andrepairstroke[j].jmolmed(berl),2007,85:1331-1338.
[48]  natarajanr,salloumfn,fisherbj,etal.hypoxiainduciblefactor-1activationbyprolyl4-hydroxylase-2genesilencingattenuatesmyocardialischemiareperfusioninjury[j].circres,2006,98:133-140.
[49]  huangm,wujc.molecularimagingofrnainterferencetherapytargetingphd2fortreatmentofmyocardialischemia[j].methodsmolbiol,2011,709:211-221.
[50]  wusr,nishiyaman,kanomr,etal.enhancementofangiogenesisthroughstabilizationofhypoxia-induciblefactor-1bysilencingprolylhydroxylasedomain-2gene[j].molther,2008,16:1227-1234.
[51]  takeday,costas,delamarree,etal.macrophageskewingbyphd2haplodeficiencypreventsischaemiabyinducingarteriogenesis[j].nature,2011,479:122-126.
[52]  wangwe,yangdz,lilp,etal.prolylhydroxylasedomainprotein2silencingenhancesthesurvivalandparacrinefunctionoftransplantedadipose-derivedstemcellsininfarctedmyocardium[j].circres,2013,113:288-300.
[53]  bzowskam,m??yk-kope?r,próchnickit,etal.antibody-basedantiangiogenicandantilymphangiogenictherapiestopreventtumorgrowthandprogression[j].actabiochimpol,2013,60:263-275.
[54]  chanda,giacciaaj.phd2intumourangiogenesis[j].brjcancer,2010,103:1-5.
[55]  chanda,kawaharatl,sutphinpd,etal.tumorvasculatureisregulatedbyphd2-mediatedangiogenesisandbonemarrow-derivedcellrecruitment[j].cancercell,2009,15:527-538.
[56]  goels,dudadg,xul,etal.normalizationofthevasculaturefortreatmentofcancerandotherdiseases[j].physiolrev,2011,91:1071-1121.
[57]  mazzonem,dettorid,leitedeoliveirar,etal.heterozygousdeficiencyofphd2restorestumoroxygenationandinhibitsmetastasisviaendothelialnormalization[j].cell,2009,136:839-851.
[58]  leitedeoliveirar,deschoemaekers,henzeat,etal.gene-targetingofphd2improvestumorresponsetochemotherapyandpreventsside-toxicity[j].cancercell,2012,22:263-277.
[59]  yeohkk,chanmc,thalhammera,etal.dual-actioninhibitorsofhifprolylhydroxylasesthatinducebindingofasecondironion[j].orgbiomolchem,2013,11:732-745.
[60]  flaggsc,martincb,taabazuingcy,etal.screeningchelatinginhibitorsofhif-prolylhydroxylasedomain2(phd2)andfactorinhibitinghif(fih)[j].jinorgbiochem,2012,113:25-30.
[61]  nangakum,izuharay,takizawas,etal.anovelclassofprolylhydroxylaseinhibitorsinducesangiogenesisandexertsorganprotectionagainstischemia[j].arteriosclerthrombvascbiol,2007,27:2548-2554.
[62]  hölscherm,silterm,krulls,etal.cardiomyocyte-specificprolyl-4-hydroxylasedomain2knockoutprotectsfromacutemyocardialischemicinjury[j].jbiolchem,2011,286:11185-11194.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133